Broadcom Is 26% Below Its High. What $10,000 Bought a Decade Ago, and When the Gains Landed.

Broadcom shares are down 26% from their $495 52-week high to roughly $369 after fiscal Q4 revenue guidance of $34.8B came in slightly below the $35.0B consensus, despite record quarterly results. AI semiconductor revenue reached $16.7B in fiscal Q3 2026, up 221% year over year, helping drive total revenue up 86% to $29.6B, net income up 216% to $13.1B, and free cash flow to $13.7B. Management expects Q4 AI semiconductor revenue of $21.7B, up 236% year over year, while the article argues the pullback presents a long-term buying opportunity based on Broadcom's decade-long 29x total-return performance with dividends reinvested.

Analysis

The selloff appears driven by a valuation-duration reset rather than deterioration in reported execution: a sub-1% revenue-guide variance triggered a far larger equity move. That creates an asymmetric setup only if custom AI silicon demand remains incremental to, rather than merely substitutive for, merchant GPU spending. AVGO is the clearest public vehicle for hyperscalers diversifying accelerator supply, while its networking content should compound with cluster scale; this is a more differentiated AI exposure than a generic semiconductor basket.

The key second-order risk is customer concentration and program timing. Custom ASIC revenue can look exceptionally durable during tape-out and deployment ramps, but order cadence is lumpy and a delayed hyperscaler platform can produce sharp sequential deceleration even with intact end demand. In the next 1-3 months, the market will focus less on headline AI revenue growth than on backlog conversion, the number of active customer programs, semiconductor gross margin, and whether VMware/software cash generation offsets cyclicality in infrastructure silicon.

Consensus may be anchoring excessively on the prior multi-year return and treating every drawdown as a repeatable buying opportunity. A recovery is not automatic: the stock needs evidence that the next AI revenue step-up is demand-backed rather than a one-quarter shipment pull-forward. Conversely, if NVDA supply improves materially, hyperscalers may accelerate ASIC diversification, benefiting AVGO even if aggregate AI capex moderates; that argues for AVGO relative strength versus NVDA on a 6-18 month view.

Key Decisions for Investors

• Accumulate AVGO in thirds over the next 2-6 weeks rather than chase a one-day reversal; add only if management reiterates the next-quarter AI trajectory and semiconductor gross margin remains stable. Thesis invalidates on a material AI-guide cut or sequential AI revenue decline not attributable to a disclosed timing shift.
• For defined downside, use a 3-6 month AVGO call spread funded partially with an out-of-the-money put spread after implied volatility normalizes post-earnings; target roughly 2:1 upside/downside. Avoid naked calls while customer-program visibility remains unverified.
• Initiate a 6-12 month relative-value position: long AVGO / short a smaller notional of NVDA. The trade expresses custom-ASIC share gains and reduces broad AI-beta exposure; stop if NVDA’s data-center growth reaccelerates while AVGO’s AI growth decelerates for two consecutive quarters.
• Monitor hyperscaler capex guidance, AVGO disclosed AI customer concentration, and VMware booking/renewal metrics before increasing gross exposure. A broad capex retrenchment or weaker software cash conversion would remove the diversification support embedded in AVGO’s valuation.